Further functional and mechanism studies of SEMA3C, FAP, COBL, DUSP5, ENDOU, and METTL7A may provide more detailed information to reveal their potential role as therapeutic targets in HNSCC. The gene discussed is SEMA3C; the disease is head and neck squamous cell carcinoma.